Experts say vaccinating teens and children is a key part of the strategy to beat COVID-19. That's because, like adults, this group also plays a role in spreading the virus. In this Motley Fool Live video recorded on May 28, 2021, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss which companies will be ready to vaccinate teens for COVID-19 ahead of the upcoming back-to-school period.
10 stocks we like better than Moderna Inc.
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 7, 2021
Olivia Zitkus: When are other vaccine producers planning to submit EUAs (Emergency Use Authorizations) for this age group or for younger kids?
Adria Cimino: Well, first, I'll start with Johnson & Johnson (NYSE: JNJ). It's a little bit farther behind. They started a teen study last month. We can expect that that's not going to be right away because they're just getting started on this. Moderna (NASDAQ: MRNA) really is the closest. They reported positive data just recently, and they said they'll ask the FDA to expand the Emergency Use Authorization in early June to cover teens. I would say it's very possible that both Moderna and Pfizer (NYSE: PFE) could be out there for the back-to-school vaccination. I'd say that Moderna really is the next one up for this.
Adria Cimino has no position in any of the stocks mentioned. Olivia Zitkus owns shares of Moderna Inc. The Motley Fool recommends Johnson & Johnson and Moderna Inc. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.